Clinical Trial Update: Effects of CHD Prevention on Lipoprotein Subclasses

View source ↗

Summary

This completed clinical trial update evaluates how prevention of coronary heart disease affects lipoprotein subclasses. The update summarizes the study findings…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED